title: Overview of the Acetylcholine Spasm Provocation Test.
abstract: The acetylcholine (ACh) spasm provocation test proposed by Yasue, Okumura et al more than a quarter-century ago has become a popular method for induction of coronary spasm. This test is safe and has a low rate of complications. However, it may be limited in its ability to document attacks in daily life because previously it was the gold-standard method for diagnosing active variant angina. There may be some clinical issues to modify for the next generation of cardiologists. A maximal ACh dose of 50/100 µg in the right coronary artery/left coronary artery is recommended in the Japanese Circulation Society guidelines. We often experienced the usefulness of a maximal ACh dose of 80/200 µg for the induction of coronary spasm in some cases with low or moderate disease activity. It may be necessary to reconsider the maximal ACh dose as a modified method for today's real-world clinical practice. In young patients with rest angina, intracoronary injection of ACh is less sensitive for diagnosis; in these cases, we recommend performing sequential spasm provocation tests. Especially in female patients, to document coronary artery spasm we recommend performing ACh tests first, instead of ergonovine tests, due to the supersensitivity of ACh. We also recommend supplementary use of ACh and ergonovine. This review summarizes our experiences with the ACh spasm provocation test over a period of 24 years. We have found it to be a reliable and useful method for contributing a variety of clinical information and recommend it to the next generation of cardiologists.
authors.affiliation: Department of Cardiology, Ehime Niihama Prefectural Hospital, Ehime, Japan.
authors.forename: Shozo
authors.initials: S
authors.lastname: Sueda
authors.affiliation: Department of Cardiology, Ehime Niihama Prefectural Hospital, Ehime, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Kohno
authors.affiliation: Department of Cardiology, Ochi Clinic, Ehime, Japan.
authors.forename: Takaaki
authors.initials: T
authors.lastname: Ochi
authors.affiliation: Department of Cardiology, Uraoka Clinic, Ehime, Japan.
authors.forename: Tadao
authors.initials: T
authors.lastname: Uraoka
mesh_terms: D000109:Acetylcholine / Q000008:administration & dosage*; D000787:Angina Pectoris / Q000175:diagnosis / Q000503:physiopathology; D017023:Coronary Angiography; D003326:Coronary Circulation; D003329:Coronary Vasospasm / Q000139:chemically induced* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial / Q000379:methods; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D014665:Vasodilator Agents; D000109:Acetylcholine